Genoox is a cloud based platform that covers the complete genomic analysis workflow providing innovative tools starting from data preprocessing to automated clinical recommendations.
Researchers and medical professionals use the Genoox platform to perform deep analysis and streamline operations following ACMG guidelines, improving clinical outcomes without the need to develop new systems or disrupt existing organizational data flows.
Genoox reduces full genome sequencing cost and time by up to 90% applying a broad array of algorithms, machine learning techniques and a proprietary genomic data structure.
Our method ensures fast turnaround time for rapid discovery and accurate clinical interpretation by enabling clinicians and researchers to perform complex genomic analyses, uncover hidden clinical insights and make new discoveries with only a few mouse clicks.
Security is paramount when we handle customer data. We have a range of accreditations and certifications associated with our security.
Genoox provides a comprehensive security, privacy, and compliance framework for genomic analysis, data management, and collaboration in the cloud. We are equipped to meet the stringent and ever-changing standards, and our security protocols are designed and managed in alignment with security best practices and a variety of IT security standards.
Our HIPAA-compliant, secure framework employs advanced technical and process controls, including Data Encryption, Data Protection, Version Control, Record Retention, Auditing, Backup and Disaster Recovery to facilitate compliance with federal regulatory agencies for clinical support.
Yes. The administrator can choose to share access with collaborators or co-workers by granting them either read-only, read/write, or administrator access.
Information about each variant is shared so other users working on the exact same variant would know it has already been observed. Users can selectively share genetic variant information through standard protocols including clinical reporting tools.
Genoox offers fully automated and customizable, lab-branded clinical coverage reports delivering intuitive and graphical gene-level decision support for physicians and collaborators, enabling integration for third-party downstream integration. users can choose from multiple output formats such as Word, PDF, XML.
Genoox developed a proprietary data compression tool that reduces a genome by up to 90% of its size, allowing organizations to create their own internal repository by storing historical databases and maintaining statistical data for each variant for advanced cross reference and comparison.
Utilizing our advanced machine learning algorithms, we instantly and automatically classify and identify novel genomic variants mutations of interest and impact based on specific phenotype, disease or treatment.
We have developed a systematic process for capturing, categorizing, and assessing the evidence on a genetic variant, then applying a formal classification based on this evidence. This method adheres closely to the recommendations from the American College of Medical Genetics (ACMG) and represents the industry standard among clinical genetic testing laboratories.
Genoox combines multiple variant calling techniques and advanced analytical tools, aggregating data from public and internal databases allowing clinicians and researchers to compare variants across various platforms.
Genoox’s default preset calls variants using GATK, FreeBayes, Mutect, Varscan and Vardict. Users can easily add their own preferred variant callers.
Genoox takes advantage of next-generation sequencing technologies, which facilitate the simultaneous analysis of all known genes associated with a certain disease. Users can easily create their own gene, disease or assay panel repository and apply them against samples.